Megadalton Solutions is an early-stage biotechnology company developing CDMS based assays for the analysis of large molecules such as gene therapies. Gene based therapies represent the next generation of medicine, and many of the platforms utilized fall outside the size range of conventional mass spectrometry. CDMS overcomes the limitations of conventional mass spectrometry to allow for the precision of mass spectrometry to be extended to this new class of therapeutics.